PDS Biotechnology (PDSB) Total Debt (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Total Debt came in at $16.9 million in Q4 2025, down 22.3% YoY from $21.7 million in Q4 2024, and down 5.73% on a QoQ basis from $17.9 million in Q3 2025.
PDS Biotechnology (PDSB) Total Debt (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 9 years of Total Debt data on file, last reported at $16.9 million in Q4 2025.
- Quarterly Total Debt fell 22.3% year-over-year to $16.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.9 million (down 22.3% YoY) and the FY2025 annual result came in at $16.9 million, down 22.3% from the prior year.
- Total Debt slipped to $16.9 million in Q4 2025, from $17.9 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $24.5 million in Q3 2024 to a low of $16.9 million in Q4 2025.
- A 4-year average of $21.8 million and a median of $23.1 million in 2022 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2024 — Total Debt climbed 4.78% — and 2025, when it fell 27.08%.
- Tracing PDSB's Total Debt over 4 years: stood at $23.0 million in 2022, then gained by 2.83% to $23.7 million in 2023, then fell by 8.31% to $21.7 million in 2024, then retreated by 22.3% to $16.9 million in 2025.
- The last three Total Debt figures came in at $16.9 million (Q4 2025), $17.9 million (Q3 2025), and $18.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | 4.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Dec 31, 2025 | 16.86 Mn |
| Sep 30, 2025 | 17.89 Mn |
| Jun 30, 2025 | 18.44 Mn |
| Mar 31, 2025 | 18.85 Mn |
| Dec 31, 2024 | 21.70 Mn |
| Sep 30, 2024 | 24.53 Mn |
| Jun 30, 2024 | 24.23 Mn |
| Mar 31, 2024 | 23.94 Mn |
| Dec 31, 2023 | 23.67 Mn |
| Sep 30, 2023 | 23.41 Mn |
| Jun 30, 2023 | 23.25 Mn |
| Mar 31, 2023 | 23.14 Mn |
| Dec 31, 2022 | 23.02 Mn |
| Sep 30, 2022 | 22.91 Mn |
| Mar 31, 2018 | 20.90 Mn |
| Dec 31, 2017 | 20.46 Mn |
| Sep 30, 2017 | 20.34 Mn |
| Jun 30, 2017 | 20.21 Mn |
| Mar 31, 2017 | 15.09 Mn |